Clinical trial
Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for…
NCT00405626 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00405626 |
|---|---|
| Title | Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH |
| Official title | Phase 2 Study of the Effect of Bellis Perenis and Arnica Montana on Post Partum Hemmorhage |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Shaare Zedek Medical Center |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hemorrhage |
| Intervention type | Drug |
| Interventions | Bellis Perenis, Arnica montana |
| Enrollment | 210 |
| Start date | Apr 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Nov 30, 2006 |
| Last update posted | Nov 30, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: